A phase II study to evaluate the safety and efficacy of topical 3% amphotericin B cream (Anfoleish) for the treatment of uncomplicated cutaneous leishmaniasis in Colombia.

BACKGROUND:Pentavalent antimonials (Sb5) are the first-line drugs for treating cutaneous leishmaniasis in Colombia; however, given problems with toxicity, compliance, availability, and cost, it is imperative to look for better therapeutic options. Intravenous amphotericin B (AmB) has been used exten...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Liliana López, Iván Vélez, Claudia Asela, Claudia Cruz, Fabiana Alves, Sara Robledo, Byron Arana
פורמט: Artigo
שפה:Inglês
יצא לאור: Public Library of Science (PLoS) 2018-07-01
סדרה:PLoS Neglected Tropical Diseases
גישה מקוונת:http://europepmc.org/articles/PMC6078324?pdf=render
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים